HIV

Small Doses: The Weekly News You Need to Know
Small Doses: The Weekly News You Need to KnowSmall doses is a weekly slideshow of the news you may have missed, made just for you and your busy lifestyle.
HIV dual therapy shows promiseA dual-drug regiment to treat HIV could soon be a reality, according to results presented at the recent Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle.
Clinical team alignment top priority for payersInvestment in resources that support clinicians and patients closer to the point of care may be the cure for what ails managed care executives.
Pharmacists improve adherence in HIV careThe HIV-specialized pharmacy model can improve adherence and outcomes for patients.
Opinion: 3 steps health plans can take to end the HIV epidemicWe have a path to ending the HIV epidemic in the United States, but it requires health plans and healthcare purchasers to take a more active role in getting us there.
How providers, payers, employers should be fighting obesityBy addressing the root problem of obesity with structured programs, providers can help patients lose weight and very possibly avoid expensive chronic illnesses as a result. Employers and payers should incentivize healthy weight by paying for obesity care and treatment, potentially reaping substantial savings in the long term.
Four developments helping address the opioid epidemicAs the opioid epidemic continues across the U.S., new treatment programs and guidelines could help reverse the trend.
FDA approves drug for pregnant women with HIVFDA recently approved an expansion to the prescribing information for darunavir (Prezista, Janssen Therapeutics), to treat pregnant women with HIV.
Increased utilization driving pharmacy spend in exchange plansExpress Scripts Exchange Pulse report found that utilization, particularly for traditional meds, was one of the biggest factors driving spending in 2015, accounting for more than half of the exchange plans $99 PMPY increase in spending between 2014 and 2015.
'I love my job,' says UCSF expert in HIV/AIDS, HCVBetty J. Dong, clinician, researcher, professor, and recipient of many honors, talks about her practice of pharmacy and public health.